| Literature DB >> 21295205 |
S R Desai1, S J Copley, R D Barker, C M Elston, R F Miller, A U Wells, S Munyati, K Nathoo, E L Corbett, R A Ferrand.
Abstract
AIM: To evaluate lung disease on chest radiography (CR), the relative frequency of CR abnormalities, and their clinical correlates in adolescents with vertically-acquired human immunodeficiency virus (HIV) infection.Entities:
Mesh:
Year: 2010 PMID: 21295205 PMCID: PMC3477630 DOI: 10.1016/j.crad.2010.10.009
Source DB: PubMed Journal: Clin Radiol ISSN: 0009-9260 Impact factor: 2.350
Observer variation between three readers for quantification of disease extent, determination of zonal distribution, and scoring of individual radiographic patterns
| Chest radiographic parameter | Kappa coefficient (weighted, Kω / unweighted, K) |
|---|---|
| Overall extent of disease | |
| Observer 1 versus 2 | Kω = 0.88 |
| Observer 1 versus 3 | Kω = 0.87 |
| Observer 2 versus 3 | Kω = 0.91 |
| Zonal disease distribution | |
| Upper zone | K = 0.80 |
| Mid zone | K = 0.57 |
| Lower zone | K = 0.69 |
| Extent of radiographic pattern | |
| Consolidation | K = 0.70 |
| Reticular pattern | N/A |
| Non-cavitating nodules | Kω = 0.26 |
| Cavitating nodules | N/A |
| Ring/tramline opacities | K = 0.51 |
| Ground-glass opacities | N/A |
| Masses | N/A |
Comparison of the prevalence of consolidation and ring/tramline opacities between patient subgroups
| In patients | Outpatients ( | |||
|---|---|---|---|---|
| Respiratory ( | Non-respiratory ( | |||
| Consolidation | 21/36 (58%) | 4/23 (17%) | 4/16 (25%) | <0.005 |
| Ring/tramlines | 21/36 (58%) | 15/23 (65%) | 6/16 (38%) | 0.21 |
Ring/tramline opacities were significantly more prevalent in the combined group of hospitalized patients [36/59 (61%)] than in outpatients [6/16 (38%); p<0.005].
Comparison of the prevalences of ring/tramline opacities in 59 inpatients with and without (1) a chronic cough, (2) a cough productive of sputum, (3) progressive dyspnoea, (4) a primary respiratory cause for admission and (5) a history of treatment with HAART
| Clinical feature present | Clinical feature absent | ||
|---|---|---|---|
| Cough ( | 11/16 (69%) | 25/43 (58%) | 0.46 |
| Productive cough ( | 5/8 (62%) | 31/51 (61%) | 0.93 |
| Progressive dyspnoea ( | 21/31 (68%) | 15/28 (54%) | 0.27 |
| Respiratory admission ( | 21/36 (58%) | 15/23 (65%) | 0.60 |
| HAART therapy (n = 21) | 12/21 (57%) | 24/38 (63%) | 0.65 |
The table describes the prevalence of ring/tramline opacities in patients with and without specific clinical features; for example, ring/tramline opacities were present in 11/16 (69%) patients with a chronic cough but also in 25/43 (58%) patients without a chronic cough. HAART, highly-active antiretroviral therapy.